Statistics from Altmetric.com
Commonly, patients with advanced malignancy often have symptoms of fatigue, tiredness and generalised body aches for which no therapy exists.1 Physicians find it challenging to palliate the intangible, commonly with undertreatment of these symptoms. Notably, hypogonadism (or low testosterone levels) is found in about two-thirds of male patients with advanced cancer. It is associated with poor nutritional status, fatigue, loss of appetite, reduced libido, decreased quality of life, insomnia and depression.2 Testosterone replacement provides pharmacopalliation of such symptoms in those who are preterminal. We report an audit of 13 inpatient males admitted under …
Contributors Both authors contributed to the writing of this manuscript/letter.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.